These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 25667668)
1. Combination of C-X-C motif chemokine 9 and C-X-C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model. Ma T; Xu J; Zhuang J; Zhou X; Lin L; Shan Z; Qi Z Exp Ther Med; 2015 Mar; 9(3):1006-1012. PubMed ID: 25667668 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of C-X-C motif chemokine 10 reduces graft loss mediated by memory CD8 Xu J; Ma T; Deng G; Zhuang J; Li C; Wang S; Dai C; Zhou X; Shan Z; Qi Z Exp Ther Med; 2018 Feb; 15(2):1560-1567. PubMed ID: 29434741 [TBL] [Abstract][Full Text] [Related]
3. CXCL9 and CXCL10 accelerate acute transplant rejection mediated by alloreactive memory T cells in a mouse retransplantation model. Zhuang J; Shan Z; Ma T; Li C; Qiu S; Zhou X; Lin L; Qi Z Exp Ther Med; 2014 Jul; 8(1):237-242. PubMed ID: 24944628 [TBL] [Abstract][Full Text] [Related]
4. [Roles of CXCL9 and CXCL10 in acute rejection after retransplantation in mice]. Zhuang J; Shan Z; Ma T; Zhou X; Qiu S Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1584-6. PubMed ID: 25146751 [TBL] [Abstract][Full Text] [Related]
5. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152 [TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice. Xu S; Chen J; Wang F; Kang X; Lan T; Wang F; Li Z; Qi Z; Xing J Transpl Immunol; 2010 Oct; 24(1):57-63. PubMed ID: 20688163 [TBL] [Abstract][Full Text] [Related]
7. Combined treatment with vitamin D3 and antibody agents suppresses secondary heart transplant rejection in the early postoperative period. Xie B; Ma Y; Xi Y; Di A; Chen X; Chen Y; Zhang L; Xu S; Wang C; Yan G; Qi Z Transpl Immunol; 2020 Apr; 59():101270. PubMed ID: 31953155 [TBL] [Abstract][Full Text] [Related]
8. [Effects and mechanism of interleukin-17-modified mouse bone marrow mesenchymal stem cells on rejection reaction of allogeneic skin transplantation in mice]. Ma TX; Xu YW; Jiang DY Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):234-243. PubMed ID: 32241050 [No Abstract] [Full Text] [Related]
10. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts. Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726 [TBL] [Abstract][Full Text] [Related]
11. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374 [TBL] [Abstract][Full Text] [Related]
12. I-TAC is a dominant chemokine in controlling skin intragraft inflammation via recruiting CXCR3+ cells into the graft. Li B; Xu W; Xu L; Jiang Z; Wen Z; Li K; Xiong S Cell Immunol; 2010; 260(2):83-91. PubMed ID: 19875106 [TBL] [Abstract][Full Text] [Related]
14. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation. Hwang MW; Matsumori A; Furukawa Y; Ono K; Okada M; Iwasaki A; Hara M; Sasayama S Circulation; 1999 Sep; 100(12):1322-9. PubMed ID: 10491378 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection. Karason K; Jernås M; Hägg DA; Svensson PA BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603 [TBL] [Abstract][Full Text] [Related]
16. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. Whiting D; Hsieh G; Yun JJ; Banerji A; Yao W; Fishbein MC; Belperio J; Strieter RM; Bonavida B; Ardehali A J Immunol; 2004 Jun; 172(12):7417-24. PubMed ID: 15187119 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984 [TBL] [Abstract][Full Text] [Related]
18. Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft. Jiankuo M; Xingbing W; Baojun H; Xiongwin W; Zhuoya L; Ping X; Yong X; Anting L; Chunsong H; Feili G; Jinquan T J Immunol; 2003 Feb; 170(3):1556-65. PubMed ID: 12538721 [TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients. Baker MS; Chen X; Rotramel AR; Nelson JJ; Lu B; Gerard C; Kanwar Y; Kaufman DB Surgery; 2003 Aug; 134(2):126-33. PubMed ID: 12947308 [TBL] [Abstract][Full Text] [Related]
20. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Nikolova Z; Hof A; Baumlin Y; Hof RP Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]